Multiple sclerosis

Active Research Protocols

  1. 05-N-0063 – NINDS Biomarkers in Multiple Sclerosis Study (BioMS)
  2. 07-N-0092 – PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [(11)C]PBR28 in Patients with Multiple Sclerosis (MS)
  3. 09-N-0032 – Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the CNS
  4. 09-N-0197 – Double Blind Placebo-Controlled Phase I/II Clinical Trial of Idebenone in Patients with Primary Progressive Multiple Sclerosis
  5. 10-N-0125 – Investigating Mechanism of Action of DAC HYP in the Treatment of High-Inflammatory Multiple Sclerosis (MS)
  6. 10-N-0212 – Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients with Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)
  7. 11-N-0116 – Manganese-Enhanced Magnetic Resonance Imaging in Healthy Volunteers and People with Multiple Sclerosis
  8. 12-N-0122 – Integrating Genetic and Environmental Risk Scores into an Algorithm to Predict Multiple Sclerosis Susceptibility
  9. 13-N-0017 – Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
  10. 13-N-0088 – Open Label Extension Trial of Idebenone for Primary Progressive Multiple Sclerosis
  11. 13-N-0104 – Natural History of Optic Neuritis
  12. 89-N-0045 – Evaluation of Progression in Multiple Sclerosis by Magnetic Resonance Imaging (MRI)
  13. 96-I-0052 – A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients with Suspected Chronic Lyme Infection and Selected Control Populations
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014